PATENT CLAIM ANALYSIS

Application Number: 16242902
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["514", "338000"]

Abstract:
The present invention is directed to indazole derivatives, pharmaceutical compositions containing them and their use in the treatment and/or prevention of disorders and conditions ameliorated by antagonizing one or more glucagon receptors, including for example metabolic diseases such as Type II diabetes mellitus and obesity.

Claim (Index 7):
A compound of  claim 4 , wherein\n R 1  is selected from the group consisting of 4-t-butyl-phenyl, 2,4-dimethyl-phenyl, 4-trifluoromethyl-phenyl, 2,4-dichloro-phenyl, 2-methyl-4-chloro-phenyl, 2-chloro-4-trifluoromethyl-phenyl and 2-methyl-4-trifluoromethyl-phenyl; a is an integer from 0 to 1; R 2  is selected from the group consisting of 4-chloro, 4-methyl, 4-methoxy, 4-ethoxy, 6-chloro and 6-methyl; R 4  is selected from the group consisting of isobutyl, 2,2-dimethyl-n-propyl, n-hexyl, 3,3,3-trifluoro-n-propyl, cyclohexyl-methyl- and cyclohexyl-ethyl; Z is selected from the group consisting of C and N; or a stereoisomer or pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 99.0
- Lexical Diversity: 1.06667
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15695118', '15695129', '15695107', '13478534', '13478568']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8268009158864044
- 35 USC 102 Novelty (BERT): 0.5946095107922604
- Combined Prediction Score: 0.8035817753769899
- Mean Citation Score: 455.527282
- Max Citation Score: 492.78116
- Similarity Product: 473.413585336237

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test